<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">Hemoglobin A1c-001453</span><br/>Reviewed date:[REDACTED] 10:27:51 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC:</td></tr><tr><td ID="result1_attr1">Hemoglobin A1c</td><td>5.2</td><td>4.8-5.6 %</td><td ID="result1_attr1_notes"><p>                                                       .</p><p>         Glycemic control for adults with diabetes: &lt;7.0</p><p>         Diabetes: &gt;6.4</p><p>         Prediabetes: 5.7 - 6.4</p></td></tr><tr><td colspan="4"><span class="content_span">CBC With Differential/Platelet-005009</span><br/>Reviewed date:[REDACTED] 10:27:35 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC:</td></tr><tr><td ID="result2_attr1">WBC</td><td>5.5</td><td>3.4-10.8 x10E3/uL</td><td/></tr><tr><td ID="result2_attr2">RBC</td><td>3.53</td><td>4.14-5.80 x10E6/uL</td><td/></tr><tr><td ID="result2_attr3">Hemoglobin</td><td>12.4</td><td>13.0-17.7 g/dL</td><td/></tr><tr><td ID="result2_attr4">Hematocrit</td><td>35.4</td><td>37.5-51.0 %</td><td/></tr><tr><td ID="result2_attr5">MCV</td><td>100</td><td>79-97 fL</td><td/></tr><tr><td ID="result2_attr6">MCH</td><td>35.1</td><td>26.6-33.0 pg</td><td/></tr><tr><td ID="result2_attr7">MCHC</td><td>35.0</td><td>31.5-35.7 g/dL</td><td/></tr><tr><td ID="result2_attr8">RDW</td><td>12.5</td><td>11.6-15.4 %</td><td/></tr><tr><td ID="result2_attr9">Platelets</td><td>213</td><td>150-450 x10E3/uL</td><td/></tr><tr><td ID="result2_attr10">Neutrophils</td><td>40</td><td>Not Estab. %</td><td/></tr><tr><td ID="result2_attr11">Lymphs</td><td>48</td><td>Not Estab. %</td><td/></tr><tr><td ID="result2_attr12">Monocytes</td><td>10</td><td>Not Estab. %</td><td/></tr><tr><td ID="result2_attr13">Eos</td><td>1</td><td>Not Estab. %</td><td/></tr><tr><td ID="result2_attr14">Basos</td><td>1</td><td>Not Estab. %</td><td/></tr><tr><td ID="result2_attr15">Neutrophils (Absolute)</td><td>2.2</td><td>1.4-7.0 x10E3/uL</td><td/></tr><tr><td ID="result2_attr16">Lymphs (Absolute)</td><td>2.6</td><td>0.7-3.1 x10E3/uL</td><td/></tr><tr><td ID="result2_attr17">Monocytes(Absolute)</td><td>0.5</td><td>0.1-0.9 x10E3/uL</td><td/></tr><tr><td ID="result2_attr18">Eos (Absolute)</td><td>0.1</td><td>0.0-0.4 x10E3/uL</td><td/></tr><tr><td ID="result2_attr19">Baso (Absolute)</td><td>0.1</td><td>0.0-0.2 x10E3/uL</td><td/></tr><tr><td ID="result2_attr20">Immature Granulocytes</td><td>0</td><td>Not Estab. %</td><td/></tr><tr><td ID="result2_attr21">Immature Grans (Abs)</td><td>0.0</td><td>0.0-0.1 x10E3/uL</td><td/></tr><tr><td colspan="4"><span class="content_span">Lipid Panel-303756</span><br/>Reviewed date:[REDACTED] 10:27:39 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC:</td></tr><tr><td ID="result3_attr1">Cholesterol, Total</td><td>137</td><td>100-199 mg/dL</td><td/></tr><tr><td ID="result3_attr2">Triglycerides</td><td>53</td><td>0-149 mg/dL</td><td/></tr><tr><td ID="result3_attr3">HDL Cholesterol</td><td>91</td><td>&gt;39 mg/dL</td><td/></tr><tr><td ID="result3_attr4">VLDL Cholesterol Cal</td><td>12</td><td>5-40 mg/dL</td><td/></tr><tr><td ID="result3_attr5">LDL Chol Calc (NIH)</td><td>34</td><td>0-99 mg/dL</td><td/></tr><tr><td colspan="4"><span class="content_span">TSH reflex to T4F-316487</span><br/>Reviewed date:[REDACTED] 10:27:44 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC:</td></tr><tr><td ID="result4_attr1">TSH</td><td>1.550</td><td>0.450-4.500 uIU/mL</td><td/></tr><tr><td colspan="4"><span class="content_span">CMP14+eGFR-334943</span><br/>Reviewed date:[REDACTED] 10:27:17 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC:</td></tr><tr><td ID="result5_attr1">Glucose</td><td>89</td><td>70-99 mg/dL</td><td/></tr><tr><td ID="result5_attr2">BUN</td><td>10</td><td>8-27 mg/dL</td><td/></tr><tr><td ID="result5_attr3">Creatinine</td><td>0.82</td><td>0.76-1.27 mg/dL</td><td/></tr><tr><td ID="result5_attr4">eGFR</td><td>92</td><td>&gt;59 mL/min/1.73</td><td/></tr><tr><td ID="result5_attr5">BUN/Creatinine Ratio</td><td>12</td><td>10-24</td><td/></tr><tr><td ID="result5_attr6">Sodium</td><td>132</td><td>134-144 mmol/L</td><td/></tr><tr><td ID="result5_attr7">Potassium</td><td>4.5</td><td>3.5-5.2 mmol/L</td><td/></tr><tr><td ID="result5_attr8">Chloride</td><td>94</td><td>96-106 mmol/L</td><td/></tr><tr><td ID="result5_attr9">Carbon Dioxide, Total</td><td>19</td><td>20-29 mmol/L</td><td/></tr><tr><td ID="result5_attr10">Calcium</td><td>9.9</td><td>8.6-10.2 mg/dL</td><td/></tr><tr><td ID="result5_attr11">Protein, Total</td><td>6.9</td><td>6.0-8.5 g/dL</td><td/></tr><tr><td ID="result5_attr12">Albumin</td><td>4.4</td><td>3.8-4.8 g/dL</td><td/></tr><tr><td ID="result5_attr13">Globulin, Total</td><td>2.5</td><td>1.5-4.5 g/dL</td><td/></tr><tr><td ID="result5_attr14">A/G Ratio</td><td>1.8</td><td>1.2-2.2</td><td/></tr><tr><td ID="result5_attr15">Bilirubin, Total</td><td>0.8</td><td>0.0-1.2 mg/dL</td><td/></tr><tr><td ID="result5_attr16">Alkaline Phosphatase</td><td>35</td><td>44-121 IU/L</td><td/></tr><tr><td ID="result5_attr17">AST (SGOT)</td><td>37</td><td>0-40 IU/L</td><td/></tr><tr><td ID="result5_attr18">ALT (SGPT)</td><td>20</td><td>0-44 IU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">Cardiovascular Report-910385</span><br/>Reviewed date:[REDACTED] 10:27:03 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC:</td></tr><tr><td ID="result6_attr1">Interpretation</td><td>Note</td><td/><td ID="result6_attr1_notes"><p>liver disease, and certain medications can cause secondary</p><p>individuals with greater than 7.5% risk may warrant more</p><p>average LDL-C reduction of 50% or more from the untreated</p><p>elevated 10-year CVD risk. If statin cannot be tolerated or</p><p>LIPID MANAGEMENT</p><p>HIGH RISK ASSESSMENT AND TREATMENT SUGGESTIONS</p><p>-------------------------------</p><p>LOW RISK ASSESSMENT AND TREATMENT SUGGESTIONS</p><p>and clinical judgment. Additional risk factors such as</p><p>LDL-C is optimal, was 57 and now is 34 mg/dL. Non-HDL</p><p>prevention, the intensity of therapy should be adjusted to</p><p>mg and rosuvastatin 20 mg.</p><p>Cholesterol is optimal, was 69 and now is 46 mg/dL.</p><p>-</p><p>personal or family history of premature CHD, smoking, and</p><p>http://tools.cardiosource.org/ASCVD-Risk-Estimator/</p><p>simvastatin 20-40 mg, pravastatin 40-80 mg, lovastatin 40</p><p>Select one patient risk category based upon medical history</p><p>-------------------------------</p><p>have CHD or a CHD risk equivalent, consider use of the</p><p>mg. HIGH intensity statin therapy generally results in an</p><p>baseline. Examples include (daily doses): atorvastatin 40-80</p><p>management).</p><p>intensive therapy. The calculator can be found at:</p><p>elevated CRP, or elevated 10-year CVD risk.</p><p>-------------------------------</p><p>premature atherosclerotic disease, elevated coronary artery</p><p>Considerations for use of statin therapy include family</p><p>coronary artery calcium score, ankle-brachial index &lt; 0.9,</p><p>increased, alternatives include use of an intestinal agent</p><p>less than 50% from the untreated baseline. Examples include</p><p>Cholesterol is optimal, was 69 and now is 46 mg/dL.</p><p>that may influence statin use include family history of</p><p>generally results in an average LDL-C reduction of 30% to</p><p>-</p><p>-</p><p>-------------------------------</p><p>the level of patient risk. MODERATE intensity statin therapy</p><p>adjudicate need for further LDL lowering therapy. Factors</p><p>Therapeutic lifestyle changes are always valuable to achieve</p><p>Cholesterol is optimal, was 69 and now is 46 mg/dL.</p><p>Pooled Cohort Equations to estimate 10-year CVD risk, as</p><p>calcium score, ankle-brachial index &lt; 0.9, elevated CRP, or</p><p>-------------------------------</p><p>present (age over 45). If the patient has CHD or a CHD risk</p><p>history of premature atherosclerotic disease, elevated</p><p>CARDIOVASCULAR REPORT:</p><p>LDL-C is optimal, was 57 and now is 34 mg/dL. Non-HDL</p><p>LDL-C is optimal, was 57 and now is 34 mg/dL. Non-HDL</p><p>patient's risk is at least LOW. One major CHD risk factor is</p><p>(ezetimibe or bile acid sequestrant) or niacin.</p><p>-</p><p>INTERMEDIATE RISK ASSESSMENT AND TREATMENT SUGGESTIONS</p><p>Consider measurement of LDL particle number or Apo B to</p><p>hypertension modify a patient's goals of therapy. In CVD</p><p>(daily doses): atorvastatin 10-20 mg, rosuvastatin 5-10 mg,</p><p>dyslipidemia. Consider evaluation if clinically indicated.</p><p>equivalent, the risk category is high. If patient does not</p><p>-------------------------------</p><p>optimal blood lipid status (diet, exercise, weight</p><p>Insulin resistance, obesity, excessive alcohol use, smoking,</p><p>Current available clinical information suggests the</p><p>Practice Guidelines. J Am Coll Cardiol 2019; 73: e285-350;</p><p>clinician should consider this information within the</p><p>These assessments and treatment suggestions are provided as</p><p>particle number or Apo B to adjudicate need for further LDL</p><p>2018 Multisociety guideline on the management of blood</p><p>increased, alternatives include use of an intestinal agent</p><p>DISCLAIMER</p><p>al. Diabetes Care 2008; 31(4):811-82.</p><p>relationship and are not intended to replace the physician's</p><p>Continue statin if in use. Consider measurement of LDL</p><p>-</p><p>in addition to other evidence and expert opinion. The</p><p>-------------------------------</p><p>[REDACTED] et al. Clin Chem 2009; 55(3):407-419; [REDACTED] et</p><p>SEE GUIDANCE FOR CARDIOVASCULAR REPORT: [REDACTED] et al.</p><p>Cardiology/American Heart Association Task Force on Clinical</p><p>lowering therapy. If statin cannot be tolerated or</p><p>context of clinical opinion and the individual patient.</p><p>a convenience in support of the physician-patient</p><p>(ezetimibe or bile acid sequestrant) or niacin.</p><p>cholesterol: a report of the American College of</p><p>clinical judgment. They are derived from national guidelines</p></td></tr><tr><td ID="result6_attr2">PDF</td><td>Not applicable</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">Occult Blood, Fecal, IA-182949</span><br/>Reviewed date:[REDACTED] 10:20:41 AM<br/>Interpretation:positive<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:<br/>Clinical Information:SRC: STOOL</td></tr><tr><td ID="result7_attr1">Occult Blood, Fecal, IA</td><td>Positive</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div>No Information</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Dabigatran Etexilate Mesylate 150 MG</td><td ID="instruction1">1 capsule Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">dilTIAZem HCl ER 120 MG</td><td ID="instruction2">1 capsule Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Famotidine 20 MG</td><td ID="instruction3">1 tablet at bedtime as needed Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Aleve 220 MG</td><td ID="instruction4">1 tablet with food or milk as needed Orally every 12 hrs</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">Flu Immunize order/Admin</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization1notes">  Immunization Given by from source eCW:: va clinic</td></tr><tr><td ID="immunization2">Fluad HD</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td/></tr><tr><td ID="immunization3">Influenza (split), 3 yrs and above</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization3notes">  Immunization Given by from source eCW:: at VA clinic</td></tr><tr><td ID="immunization4">Influenza (split), 3 yrs and above</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization4notes">  Immunization Given by from source eCW:: at VA clinic</td></tr><tr><td ID="immunization5">Moderna Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization5notes">  Immunization Given by from source eCW:: va clinic</td></tr><tr><td ID="immunization6">Moderna Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization6notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization7">Pneumococcal polysaccharide PPV23</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization7notes">  Immunization Given by from source eCW:: at va clinic</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Former Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">AUDIT-C (Standard)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>Yes</td><td/></tr><tr><td>How often did you have six or more drinks on one occasion in the past year?</td><td>4 or more times a week (4 points)</td><td/></tr><tr><td>How many drinks did you have on a typical day when you were drinking in the past year?</td><td>1 or 2 drinks (0 point)</td><td/></tr><tr><td>How often did you have a drink containing alcohol in the past year?</td><td>Monthly or less (1 point)</td><td/></tr><tr><td>Points</td><td>5</td><td/></tr><tr><td>Interpretation</td><td>Positive</td><td/></tr></tbody></table><span class="content_span">Tobacco Control (Standard)</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>Former smoker</td><td/></tr><tr><td>How long has it been since you last smoked?</td><td>Greater than 10 years</td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>234467004</td><td ID="Problem1">Other thrombophilia (D68.69)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Malnutrition of mild degree ([REDACTED]: 75% to less than 90% of standard weight) (77702009)</td><td ID="Problem2">Mild protein-calorie malnutrition (E44.1)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Essential tremor (609558009)</td><td ID="Problem3">Essential tremor (G25.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Chronic atrial fibrillation (disorder) (426749004)</td><td ID="Problem4">Chronic atrial fibrillation, unspecified (I48.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Gastroesophageal reflux disease (235595009)</td><td ID="Problem5">GERD without esophagitis (K21.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>13645005</td><td ID="Problem6">Chronic obstructive pulmonary disease, unspecified COPD type (J44.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>66590003</td><td ID="Problem7">Uncomplicated alcohol dependence (F10.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hyperlipidemia (55822004)</td><td ID="Problem8">Hyperlipidemia (E78.5)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Screening for malignant neoplasm of colon (275978004)</td><td ID="Problem9">Encounter for fecal immunochemical test screening (Z12.11)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>70995007</td><td ID="Problem10">Pulmonary hypertension (I27.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>BMI less than 20 (310252000)</td><td ID="Problem11">BMI &lt;20 (Z68.1)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hypertension (38341003)</td><td ID="Problem12">Hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Generalized osteoarthritis (201819000)</td><td ID="Problem13">Primary OA (M15.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>73 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Temperature</th><td>98.2 degrees Fahrenheit</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Oximetry</th><td>100 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Blood pressure diastolic</th><td>80 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Weight-kg</th><td>63.5 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Height</th><td>72 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Blood pressure systolic</th><td>132 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Weight</th><td>140 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">BMI</th><td>18.99 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED][REDACTED] 1</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Prostate cancer screening Z12.5</td></tr><tr><td>MCM [REDACTED][REDACTED] 1</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hyperlipidemia E78.5</td></tr><tr><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hyperlipidemia E78.5 and Hypertension I10</td></tr><tr><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Chronic atrial fibrillation, unspecified I48.20 ; Primary OA M15.0 ; GERD without esophagitis K21.9 ; Hyperlipidemia E78.5 ; Deficiency of other specified B group vitamins E53.8 ; Hypertension I10 ; Uncomplicated alcohol dependence F10.20 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Pulmonary hypertension I27.20 ; Other thrombophilia D68.69 ; BMI &lt;20 Z68.1 ; Anemia, unspecified D64.9 ; Essential tremor G25.0 and Mild protein-calorie malnutrition E44.1</td></tr><tr><td>[REDACTED][REDACTED] 1</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Chronic atrial fibrillation, unspecified I48.20 ; Primary OA M15.0 ; GERD without esophagitis K21.9 ; Hyperlipidemia E78.5 ; Deficiency of other specified B group vitamins E53.8 ; Hypertension I10 ; Uncomplicated alcohol dependence F10.20 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Pulmonary hypertension I27.20 ; Other thrombophilia D68.[REDACTED] and BMI &lt;20 Z68.1</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Chronic atrial fibrillation, unspecified (ICD-10 - I48.20)</td><td/><td> Continue medication</td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Primary OA (ICD-10 - M15.0)</td><td/><td> rom, exercise, stretching</td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Chronic atrial fibrillation, unspecified (ICD-10 - I48.20)</td><td/><td> Continue medication</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Primary OA (ICD-10 - M15.0)</td><td/><td> rom, exercise, stretching</td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Prostate cancer screening (ICD-10 - Z12.5)</td><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>GERD without esophagitis (ICD-10 - K21.9)</td><td/><td> continue famotidine</td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>GERD without esophagitis (ICD-10 - K21.9)</td><td/><td> continue famotidine</td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td>Continue diet and exercise.</td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td>Continue diet and exercise.</td><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Deficiency of other specified B group vitamins (ICD-10 - E53.8)</td><td/><td> 400mcg folate daily discussed</td><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Deficiency of other specified B group vitamins (ICD-10 - E53.8)</td><td/><td> 400mcg folate daily discussed</td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Hypertension (ICD-10 - I10)</td><td/><td>COntinue medications, controlled.</td><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Hypertension (ICD-10 - I10)</td><td/><td>COntinue medications, controlled.</td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Uncomplicated alcohol dependence (ICD-10 - F10.20)</td><td/><td>Advised to cut down on ETOH.</td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Uncomplicated alcohol dependence (ICD-10 - F10.20)</td><td/><td>Advised to cut down on ETOH.</td><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td/><td>Stable, denies any sob at rest or during activity.</td><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td/><td>Stable, denies any sob at rest or during activity.</td><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Pulmonary hypertension (ICD-10 - I27.20)</td><td/><td>Continue to monitor closely.</td><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Pulmonary hypertension (ICD-10 - I27.20)</td><td/><td>Continue to monitor closely.</td><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td/><td>continue medication, clotting/bleeding discussed</td><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td/><td>continue medication, clotting/bleeding discussed</td><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>BMI &lt;20 (ICD-10 - Z68.1)</td><td/><td>wt.  managment discussed</td><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>BMI &lt;20 (ICD-10 - Z68.1)</td><td/><td>wt.  managment discussed</td><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Anemia, unspecified (ICD-10 - D64.9)</td><td/><td>Mild; advised patient on GI evaluation as he has had positive fecal occult in the past; patient declines he knows risk of cancer; patient advised on cutting down on EtOH</td><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Essential tremor (ICD-10 - G25.0)</td><td/><td>Patient prefers conservative management</td><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Mild protein-calorie malnutrition (ICD-10 - E44.1)</td><td/><td>Advised on GI f/u; boost or ensure discussed; pt. wants conservative management and declines GI follow-up</td><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Other</td><td/><td><p>patient seen along with ARNP</p><p>declines colonoscopy</p></td><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Other</td><td/><td>Patient seen along with ARNP Gene
</td><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">TSH+Free T4-224576</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">Lipid Panel-303756</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">CMP14+eGFR-334943</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">Hemoglobin A1c, Fasting</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">CBC With Differential/Platelet</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">Lipid Panel, Fasting</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">CMP14+eGFR</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">Occult Blood, Fecal, IA - 182949</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">ACUTE HEPATITIS PANEL (REFL)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest11">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest12">Ultrasound : Right Upper Quadrant</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">CHEST PA &amp; LATERAL</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 08:00:00 AM, [REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Careplus MCR</td><td>PO BOX 31286 [REDACTED], FL 33631-3320</td><td>[REDACTED]</td><td>5851751</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>HTN, HLD, AFIB, Valvular heart disease, Pulmonary HTN</td><td/></tr><tr><td>COPD- PFT 5/2021</td><td/></tr><tr><td>Primary oa</td><td/></tr><tr><td>GERD</td><td/></tr><tr><td>Elevated PSA</td><td/></tr><tr><td>Elevated LE, negative hepatitis, us with fatty liver, cyst</td><td/></tr><tr><td>alcohol dependence with abuse- per VA</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>MV and AV Repair</td><td>2015</td></tr><tr><td>MAZE</td><td>2015-02</td></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>MAZE</td><td>2015-02</td></tr></tbody></table></div><br/><br/>
</body></html>